Galectin-3 Inhibition in COVID-19
Am J Respir Crit Care Med
.
2023 Jan 15;207(2):118-120.
doi: 10.1164/rccm.202209-1758ED.
Authors
Kiran Reddy
1
2
,
Alistair Nichol
3
4
5
6
,
Daniel F McAuley
1
2
Affiliations
1
School of Medicine, Dentistry and Biomedical Sciences Queen's University Belfast Belfast, Northern Ireland.
2
Regional Intensive Care Unit Royal Victoria Hospital Belfast, Northern Ireland.
3
Australian and New Zealand Intensive Care Research Centre Monash University Melbourne, Victoria, Australia.
4
Department of Intensive Care Alfred Hospital Melbourne, Victoria, Australia.
5
Department of Anaesthesia and Intensive Care Medicine St. Vincent's University Hospital Dublin, Ireland.
6
School of Medicine and Medical Sciences University College Dublin Dublin, Ireland.
PMID:
36154818
PMCID:
PMC9893318
DOI:
10.1164/rccm.202209-1758ED
No abstract available
Publication types
Editorial
Comment
MeSH terms
COVID-19*
Galectin 3
Humans
Pneumonia*
Substances
Galectin 3